417 results on '"Vitorica, Javier"'
Search Results
2. Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus
3. Reactive astrocyte nomenclature, definitions, and future directions
4. Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
5. Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
6. Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
7. Hypoxia compromises the mitochondrial metabolism of Alzheimer’s disease microglia via HIF1
8. MONOCYTE‐DERIVED CELLS INVADE AMYLOID PLAQUES IN HUMAN ALZHEIMER’S DISEASE HIPPOCAMPUS
9. Neurons and astrocytes derived from human iPSCs to model Alzheimer´s disease
10. Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity
11. PERIPHERAL MYELOID CELLS INFILTRATE THE HIPPOCAMPUS OF ALZHEIMER´S DISEASE PATIENTS
12. CO-CULTURES BETWEEN NEURONS AND ASTROCYTES TO ADDRESS ALZHEIMER´S DISEASE PATHOLOGY
13. Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases
14. Non-productive angiogenesis disassembles Aß plaque-associated blood vessels
15. Neuroinflammation in Alzheimer's disease
16. Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model
17. Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity.
18. In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer¿s disease pathology
19. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
20. Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer’s disease model
21. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice
22. Neocortical tissue recovery in severe congenital obstructive hydrocephalus after intraventricular administration of bone marrow-derived mesenchymal stem cells
23. Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations
24. Generation of Periventricular Reactive Astrocytes Overexpressing Aquaporin 4 Is Stimulated by Mesenchymal Stem Cell Therapy
25. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease
26. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
27. Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
28. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimerʼs disease
29. Metabolomic research on the role of interleukin-4 in Alzheimer’s disease
30. Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
31. Tau pathology and astroglial reactivity: a comparative study of two mouse models of tauopathy
32. Human pluripotent stem cell-derived astrocytes from alzheimer´s disease patients for disease modeling
33. Diversity of plaque-associated myeloid cells subtypes in human alzheimer’s disease brain
34. Cytotoxicity and Effects on the Synapsis Induced by Pure Cylindrospermopsin in an E17 Embryonic Murine Primary Neuronal Culture in a Concentration- and Time-Dependent Manner
35. Regional difference in inflammatory response to LPS-injection in the brain: Role of microglia cell density
36. Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
37. Animal and Cellular Models of Alzheimer's Disease: Progress, Promise, and Future Approaches.
38. Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer’s Disease
39. Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
40. GALECTIN-3 REDUCES AMYLOID BETA PLAQUE AND ASSOCIATED DYSTROPHIES ON APP MICE
41. PERIPHERAL MYELOID CELLS INFILTRATE THE HIPPOCAMPUS OF ALZHEIMER´S DISEASE PATIENTS
42. CO-CULTURES BETWEEN NEURONS AND ASTROCYTES TO ADDRESS ALZHEIMER´S DISEASE PATHOLOGY
43. Expression of Gls and Gls2 glutaminase isoforms in astrocytes
44. Fast and efficient generation of oligodendrocytes from human induced pluripotent stem cells (hiPSCs)
45. Coexistance of different damage-associated myeloid populations in the hippocampus of Alzheimer's patients
46. Understanding microglial responses in the frontal cortex of alzheimer´s disease patients
47. Microtubule stabilization reduces amyloid pathology and improves synaptic/memory deficits in APP/PS1 mice
48. Increased levels of tumour necrosis factor alpha (TNFα) but not transforming growth factor-beta 1 (TGFβ1) are associated with the severity of congenital hydrocephalus in the hyh mouse
49. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus
50. Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.